Cargando…
Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine
Francisella tularensis (F. tularensis) is an intracellular pathogen that causes a potentially debilitating febrile illness known as tularemia. F. tularensis can be spread by aerosol transmission and cause fatal pneumonic tularemia. If untreated, mortality rates can be as high as 30%. To study the ho...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564149/ https://www.ncbi.nlm.nih.gov/pubmed/32722207 http://dx.doi.org/10.3390/vaccines8030413 |
_version_ | 1783595646641504256 |
---|---|
author | Chang, Yie-Hwa Duong, Duc M. Goll, Johannes B. Wood, David C. Jensen, Travis L. Yin, Luming Gelber, Casey E. Seyfried, Nicholas T. Anderson, Evan Natrajan, Muktha S. Rouphael, Nadine Johnson, Robert A. Sanz, Patrick Mulligan, Mark J. Hoft, Daniel F. |
author_facet | Chang, Yie-Hwa Duong, Duc M. Goll, Johannes B. Wood, David C. Jensen, Travis L. Yin, Luming Gelber, Casey E. Seyfried, Nicholas T. Anderson, Evan Natrajan, Muktha S. Rouphael, Nadine Johnson, Robert A. Sanz, Patrick Mulligan, Mark J. Hoft, Daniel F. |
author_sort | Chang, Yie-Hwa |
collection | PubMed |
description | Francisella tularensis (F. tularensis) is an intracellular pathogen that causes a potentially debilitating febrile illness known as tularemia. F. tularensis can be spread by aerosol transmission and cause fatal pneumonic tularemia. If untreated, mortality rates can be as high as 30%. To study the host responses to a live-attenuated tularemia vaccine, peripheral blood mononuclear cell (PBMC) samples were assayed from 10 subjects collected pre- and post-vaccination, using both the 2D-DIGE/MALDI-MS/MS and LC-MS/MS approaches. Protein expression related to antigen processing and presentation, inflammation (PPARγ nuclear receptor), phagocytosis, and gram-negative bacterial infection was enriched at Day 7 and/or Day 14. Protein candidates that could be used to predict human immune responses were identified by evaluating the correlation between proteome changes and humoral and cellular immune responses. Consistent with the proteomics data, parallel transcriptomics data showed that MHC class I and class II-related signals important for protein processing and antigen presentation were up-regulated, further confirming the proteomic results. These findings provide new biological insights that can be built upon in future clinical studies, using live attenuated strains as immunogens, including their potential use as surrogates of protection. |
format | Online Article Text |
id | pubmed-7564149 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-75641492020-10-26 Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine Chang, Yie-Hwa Duong, Duc M. Goll, Johannes B. Wood, David C. Jensen, Travis L. Yin, Luming Gelber, Casey E. Seyfried, Nicholas T. Anderson, Evan Natrajan, Muktha S. Rouphael, Nadine Johnson, Robert A. Sanz, Patrick Mulligan, Mark J. Hoft, Daniel F. Vaccines (Basel) Article Francisella tularensis (F. tularensis) is an intracellular pathogen that causes a potentially debilitating febrile illness known as tularemia. F. tularensis can be spread by aerosol transmission and cause fatal pneumonic tularemia. If untreated, mortality rates can be as high as 30%. To study the host responses to a live-attenuated tularemia vaccine, peripheral blood mononuclear cell (PBMC) samples were assayed from 10 subjects collected pre- and post-vaccination, using both the 2D-DIGE/MALDI-MS/MS and LC-MS/MS approaches. Protein expression related to antigen processing and presentation, inflammation (PPARγ nuclear receptor), phagocytosis, and gram-negative bacterial infection was enriched at Day 7 and/or Day 14. Protein candidates that could be used to predict human immune responses were identified by evaluating the correlation between proteome changes and humoral and cellular immune responses. Consistent with the proteomics data, parallel transcriptomics data showed that MHC class I and class II-related signals important for protein processing and antigen presentation were up-regulated, further confirming the proteomic results. These findings provide new biological insights that can be built upon in future clinical studies, using live attenuated strains as immunogens, including their potential use as surrogates of protection. MDPI 2020-07-24 /pmc/articles/PMC7564149/ /pubmed/32722207 http://dx.doi.org/10.3390/vaccines8030413 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Chang, Yie-Hwa Duong, Duc M. Goll, Johannes B. Wood, David C. Jensen, Travis L. Yin, Luming Gelber, Casey E. Seyfried, Nicholas T. Anderson, Evan Natrajan, Muktha S. Rouphael, Nadine Johnson, Robert A. Sanz, Patrick Mulligan, Mark J. Hoft, Daniel F. Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine |
title | Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine |
title_full | Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine |
title_fullStr | Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine |
title_full_unstemmed | Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine |
title_short | Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine |
title_sort | proteomic analysis of human immune responses to live-attenuated tularemia vaccine |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564149/ https://www.ncbi.nlm.nih.gov/pubmed/32722207 http://dx.doi.org/10.3390/vaccines8030413 |
work_keys_str_mv | AT changyiehwa proteomicanalysisofhumanimmuneresponsestoliveattenuatedtularemiavaccine AT duongducm proteomicanalysisofhumanimmuneresponsestoliveattenuatedtularemiavaccine AT golljohannesb proteomicanalysisofhumanimmuneresponsestoliveattenuatedtularemiavaccine AT wooddavidc proteomicanalysisofhumanimmuneresponsestoliveattenuatedtularemiavaccine AT jensentravisl proteomicanalysisofhumanimmuneresponsestoliveattenuatedtularemiavaccine AT yinluming proteomicanalysisofhumanimmuneresponsestoliveattenuatedtularemiavaccine AT gelbercaseye proteomicanalysisofhumanimmuneresponsestoliveattenuatedtularemiavaccine AT seyfriednicholast proteomicanalysisofhumanimmuneresponsestoliveattenuatedtularemiavaccine AT andersonevan proteomicanalysisofhumanimmuneresponsestoliveattenuatedtularemiavaccine AT natrajanmukthas proteomicanalysisofhumanimmuneresponsestoliveattenuatedtularemiavaccine AT rouphaelnadine proteomicanalysisofhumanimmuneresponsestoliveattenuatedtularemiavaccine AT johnsonroberta proteomicanalysisofhumanimmuneresponsestoliveattenuatedtularemiavaccine AT sanzpatrick proteomicanalysisofhumanimmuneresponsestoliveattenuatedtularemiavaccine AT mulliganmarkj proteomicanalysisofhumanimmuneresponsestoliveattenuatedtularemiavaccine AT hoftdanielf proteomicanalysisofhumanimmuneresponsestoliveattenuatedtularemiavaccine |